Latest IKT reports update at 2024-05-15: 2024-Q12023-Q42023-Q1
Inhibikase Therapeutics logo
Inhibikase Therapeutics IKT
$ 1.36 -2.86%

Inhibikase Therapeutics P/E Ratio 2011-2024 | IKT

Annual P/E Ratio Inhibikase Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.645 -0.18 -1.31 -19.2 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.18 -19.2 -5.33